Medicinal Products

Simponi

The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.

Name Simponi
Active Substance golimumab
Prescription na recept
Type of prescription ograničeni recept (otopina za injekciju u napunjenoj brizgalici, otopina za injekciju u napunjenoj štrcaljki)
Distribution u ljekarni
ATC Code L04AB06
Medicinal product marketed in the Croatia Nestašica
Summary of product characteristics (SmPC), labelling and package leaflet (PL) download
Link to the European Medicines Agency's (EMA) product information download
Link to the European Commission's (EC) decisions download
Educational materials
for patients / caregivers
Kartica s podsjetnikom za bolesnika

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o važnim izmjenama uputa za ubrizgavanje brizgalicom SmartJect napunjenom lijekom Simponi (golimumab) 09.08.2023 Janssen Biologics B.V.
Back